The evaluation of ozone and betahistine in the treatment of tinnitus

European Archives of Oto-Rhino-Laryngology

Volumn 270, Issue 7, 2013, Pages 1999-2006

  Sönmez, Onur ^a   Külahli, Ismail ^b   Vural, Alperen ^b,c   Şahin, Mehmet Ilhan ^b   Aydin, Mesut ^b  

^a Nevsehir Dr I Sevki Atasagun State Hospital   (Turkey)

^b ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Betahistine; Ozone; Tinnitus

Indexed keywords

BETAHISTINE; OZONE;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEARTBURN; HUMAN; LOUDNESS; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTCOME ASSESSMENT; OZONE THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TINNITUS; TINNITUS HANDICAP INVENTORY; TREATMENT DURATION;

ADULT; AGED; ANALYSIS OF VARIANCE; BETAHISTINE; CASE-CONTROL STUDIES; FEMALE; HISTAMINE AGONISTS; HUMANS; MALE; MIDDLE AGED; OZONE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TINNITUS;

EID: 84878791840     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-2228-8     Document Type: Article

References (54)

1. Eggermont JJ (2003) Central tinnitus. Auris Nasus Larynx 30:7-12
2. Jastreboff PJ, Jastreboff MM (2000) Tinnitus Retraining Therapy (TRT) as a method for treatment of tinnitus and hyperacusis patients. J Am Acad Audiol 11(3):162-177
3. Axelsson A, Ringdahl A (1989) Tinnitus - a study of its prevalence and characteristics. Br J Audiol 23(1):53-62. doi: 10.3109/03005368909077819
4. Megwalu UC, Finnell JE, Piccirillo JF (2006) The effects of melatonin on tinnitus and sleep. Otolaryngol Head Neck Surg 134(2):210-213. doi: 10.1016/j.otohns.2005.10.007
5. Canis M, Olzowy B, Welz C, Suckfull M, Stelter K (2011) Simvastatin and Ginkgo biloba in the treatment of subacute tinnitus: a retrospective study of 94 patients. Am J Otolaryngol 32(1):19-23. doi: 10.1016/j.amjoto.2009.09.004
6. Miller JM, Ren TY, Nuttall AL (1995) Studies of inner ear blood flow in animals and human beings. Otolaryngol Head Neck Surg 112(1):101-113. doi: 10.1016/S0194-5998(95)70308-X
7. Baguley DM (2002) Mechanisms of tinnitus. Br Med Bull 63:195-212
8. Jastreboff PJ (1990) Phantom auditory perception (tinnitus): mechanisms of generation and perception. Neurosci Res 8(4):221-254
9. Moller AR (2003) Pathophysiology of tinnitus. Otolaryngol Clin North Am 36 (2):249-266, v-vi
10. Kaltenbach JA (2000) Neurophysiologic mechanisms of tinnitus. J Am Acad Audiol 11(3):125-137
11. Antonio P, Borghi C, Ferri GG (2010) Drugs and tinnitus: a review of a controversial matter. Audiol Med 8(1):1-4. doi: 10.3109/16513861003647027
12. Han BI, Lee HW, Kim TY, Lim JS, Shin KS (2009) Tinnitus: characteristics, causes, mechanisms, and treatments. J Clin Neurol 5(1):11-19. doi: 10.3988/jcn.2009.5.1.11
13. Bocci VA (2006) Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res 37(4):425-435. doi: 10.1016/j.arcmed.2005.08.006
14. Velio B (2005) OZONE - a new medical drug. Springer, Netherlands, 20:83
15. Bocci V, Zanardi I, Travagli V (2011) Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects. Med Gas Res 1(1):6. doi: 10.1186/2045-9912-1-6
16. Pryor WA, Squadrito GL, Friedman M (1995) The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 19(6):935-941. doi: 10.1016/0891-5849(95)02033-7
17. Phillips JS, Prinsley PR (2008) Prescribing practices for Betahistine. Br J Clin Pharmacol 65(4):470-471
18. Laurikainen E, Miller J, Nuttall A, Quirk W (1998) The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol 255(3):119-123
19. Schmidt JT, Huizing EH (1992) The clinical drug trial in Menière's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl 497:1
20. Jakobs P, Martin G (1978) Springer HNO. The therapy of tinnitus resulting from blast injury. HNO 26:104-106
21. Ma F, Xin Y, Zhao Y, Lü J (2006) Efficacy of Betahistine Mesilate combined with Flunarizine Hydrochloride for treating tinnitus. Zhonghua er bi yan hou tou jing wai ke za zhi = Chin J Otorhinolaryngol Head Neck Surg 41 (4):269
22. James A, Burton MJ (2001) Betahistine for Ménière's disease or syndrome. Cochrane Database Syst Rev (1):CD001873. doi: 10.1002/14651858. CD001873
23. Akkuzu B, Yilmaz I, Cakmak O, Ozluoglu LN (2004) Efficacy of misoprostol in the treatment of tinnitus in patients with diabetes and/or hypertension. Auris Nasus Larynx 31(3):226-232
24. Yilmaz I, Akkuzu B, Çakmak Ö, Özlüoglu LN (2004) Misoprostol in the treatment of tinnitus: a double-blind study. Otolaryngol Head Neck Surg 130(5):604
25. Arda HN, Tuncel U, Akdogan O, Ozluoglu LN (2003) The role of zinc in the treatment of tinnitus. Otology Neurotol 24(1):86
26. Rybak LP (2007) Vestibüler ve Işitsel Toksisite. In: Cummings CW (ed) Otolaringoloji Baş ve Boyun Cerrahisi, vol 4, 5th edn. Güneş TIp Kitabevi, Ankara, pp 2933-2943
27. Jastreboff P, Gray W, Mattox D (1998) Tinnitus and hyperacusis. In: Cummings C, Frederickson J, Harker L et al (eds) Otolaryngology Head and Neck Surgery, 3rd edn. Mosby-Year Book, St. Louis, pp 3198-3222
28. Meikle MB, Stewart BJ, Griest SE, Henry JA (2008) Tinnitus outcomes assessment. Trends in Amplif 12(3):223-235
29. Newman CW, Sandridge SA (2004) Tinnitus questionnaires. In: Snow JB (ed) Tinnitus: Theory and management. BC Decker Inc, Hamilton, pp 237-254
30. Henry JA, Meikle MB (2000) Psychoacoustic measures of tinnitus. J Am Acad Audiol 11(3):138
31. Tyler R (2000) Psychoacoustical measurement. Tinnitus Handbook. Singular Publishing Group, San Diego, pp 149-180
32. Hiller W, Goebel G (2006) Factors influencing tinnitus loudness and annoyance. Arch Otolaryngol Head Neck Surg 132(12):1323
33. Giunta R, Coppola A, Luongo C, Sammartino A, Guastafierro S, Grassia A, Giunta L, Mascolo L, Tirelli A, Coppola L (2001) Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease. Ann Hematol 80(12):745-748
34. Romero A, Menéndez S, Gómez M, Ley J (1993) La ozonoterapia en los estadios avanzados de la aterosclerosis obliterante. Angiologia 45:146-148
35. Duplaa R, Planas G (1991) La ozonoterapia en el tratamiento de las úlceras crónicas de las extremidades inferiores. Angiologia 43
36. Bocci V (1996) Does ozone therapy normalize the cellular redox balance?: implications for the therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses 46(2):150-154
37. Hernández F, Menendez S, Wong R (1995) Decrease of blood cholesterol and stimulation of antioxidative response in cardiopathy patients treated with endovenous ozone therapy. Free Radic Biol Med 19(1):115-119
38. Leon O, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, Cruz E, Bocci V (1998) Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediat Inflamm 7:289-294
39. Barber E, Menéndez S, Leon O, Barber M, Merino N, Calunga J, Cruz E, Bocci V (1999) Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia. Mediat Inflamm 8(1):37-41
40. Peralta C, Leon O, Xaus C, Prats N, Jalil E, Planell ES, Puig-Parellada P, Gelpi E, Rosello-Catafau J (1999) Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res 31(3):191-196
41. Bocci V, Valacchi G, Corradeschi F, Aldinucci C, Silvestri S, Paccagnini E, Gerli R (1998) Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone. J Biol Regul Homeost Agents 12(3):67
42. Coppola L, Giunta R, Verrazzo G, Luongo C, Sammartino A, Vicario C, Giugliano D (1995) Infuence of ozone on haemoglobin oxygen affinity in Type-2 diabetic patients with peripheral vascular disease: in vitro studies. Diabète et métabolisme 21(4):252-255
43. KaÅmierczak H, Pawlak-Osińska K, KaÅmierczak W (2004) Betahistine in vertebrobasilar insufficiency. Int Tinnitus J 10(2):191
44. Albera R, Ciuffolotti R, Di Cicco M, De Benedittis G, Grazioli I, Melzi G, Mira E, Pallestrini E, Passali D, Serra A (2003) Double-blind, randomized, multicenter study comparing the effect of betahistine and flunarizine on the dizziness handicap in patients with recurrent vestibular vertigo. Acta Oto Laryngol 123(5):588
45. Suga F, Snow JB Jr (1969) Cochlear blood flow in response to vasodilating drugs and some related agents. Laryngoscope 79(11):1956-1979
46. Rivera V, Meyer J, Baer P, Faibish G, Mathew N, Hartmann A (1974) Vertebrobasilar arterial insufficiency with dementia. Controlled trials of treatment with betahistine hydrochloride. J Am Geriatr Soc 22(9):397
47. Petrova D, Sachansca T, Datcov E (2004) Investigation of Betaserc in auditory and vestibular disturbances. Int Tinnitus J 10(2):177
48. Dobie RA (1999) A review of randomized clinical trials in tinnitus. Laryngoscope 109(8):1202-1211
49. Pyykkö I, Zou J, Kentala E, Stephens D (2008) Tinnitus treatment: Are drugs effective? Audiol Med 6(1):25-39
50. Nakashima T, Naganawa S, Sone M, Tominaga M, Hayashi H, Yamamoto H, Liu X, Nuttall AL (2003) Disorders of cochlear blood flow. Brain Res Rev 43(1):17-28
51. Lamm K, Arnold W (1996) Noise-induced cochlear hypoxia is intensity dependent, correlates with hearing loss and precedes reduction of cochlear blood flow. Audiol Neurotol 1(3):148-160
52. 2 and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 141(1-2):199-219
53. Bennett MH, Kertesz T, Yeung P (2007) Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev 24(1):CD004739
54. Elgoyhen AB, Langguth B (2010) Pharmacological approaches to the treatment of tinnitus. Drug Discov Today 15(7-8):300-305. doi: 10.1016/j.drudis.2009.11.003